Abstract
As society continues to take its first cautious steps out of the COVID-19 pandemic, researchers, including vaccine developers, continue to reflect on the challenges that they faced and overcame together during the last 2 years and the improvements necessary for better pandemic preparedness in future. Now more than ever, the world is recognizing the importance of vaccines, and the European Research Infrastructure for Translational Medicine (EATRIS) and its infrastructure partners across Europe and beyond have strived to accelerate promising candidates through the R&D pipeline, by offering innovative services to vaccine developers in academic and industry settings.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
